7134
N. B. Palakurthy, B. Mandal / Tetrahedron Letters 52 (2011) 7132–7134
single crystal XRD (Fig. 1, characterization data of all the reaction
products including crystallographic data are provided in the
Supplementary data in detail).
References and notes
1. (a) Navia, M. A. Science 2000, 288, 2132; (b) Hansch, C.; Sammaes, P. G.; Taylor,
J. B. In Comprehensive Medicinal Chemistry; Pergamon Press: Oxford, 1990; Vol.
2, Chapter 7.1; (c) Yan, L.; Bertarelli, D. C.; Hayallah, A. M.; Meyer, H.; Klotz, K.
N.; Müller, C. E. J. Med. Chem. 2006, 49, 4384.
2. (a) Roush, W. R.; Gwaltney, S. L.; Cheng, J.; Scheidt, K. A.; McKerrow, J. H.;
Hansell, E. J. Am. Chem. Soc. 1998, 120, 10994; (b) Yoshino, H.; Ueda, N.; Niijima,
J.; Sugumi, H.; Kotake, Y.; Koyanagi, N.; Yoshimatsu, K.; Asada, M.; Watanabe,
T.; Nagaau, T.; Tsukahara, K.; Iijima, A.; Kitoh, K. J. Med. Chem. 1992, 35, 2496;
(c) Supuran, C. T.; Casini, A.; Scozzafava, A. Med. Res. Rev. 2003, 5, 535; (d)
Scozzafava, A.; Owa, T.; Mostrolorenzo, A.; Supuran, C. T. Curr. Med. Chem. 2003,
10, 925.
3. (a) Feng, Y.; Xiaomin, S.; Zhichao, J.; Shiganag, W.; Xinmiao, L.; Jinxing, Y. Chem.
Commun. 2010, 4589; (b) Wei, J.; Xinxheng, L.; Yongbo, H.; Fan, W.; Boshun, W.
Chem. Eur. J. 2010, 16, 8259.
4. (a) Yuan, W.; Fearon, K.; Gelb, M. H. J. Org. Chem. 1989, 54, 906; (b) Kabalka, G.
W.; Varma, M.; Varma, R. S. J. Org. Chem. 1986, 51, 2386.
5. Sulfonamide synthesis from tosyl chlorides using catalysts: (a) Sridhar, B.;
Srinivas, B.; Pavan, K. V.; Narender, M.; Rama, R. K. Adv. Synth. Catal. 2007, 349,
1873; (b) Joong-Gon, K.; Doo, O. J. Synlett 2007, 2501; (c) Meshram, G. A.;
Vishvanath, D. P. Tetrahedron Lett. 2009, 50, 1117; Using base: (d) Xiaohu, D.;
Neelakandha, S. M. Green. Chem. 2006, 8, 835; Directly from thiols: Kiumars, B.;
Mohammad, M. K.; Mehdi, S. J. Org. Chem. 2009, 74, 9287.
6. (a) Stephen, C.; Jonathan, D. W.; Duncan, B. J. J. Am. Chem. Soc. 2004, 126, 1024;
(b) Stephen, C.; Jonathan, D.; Hanna, D.; Sjoerd, N.; Duncan, B. J. Org. Lett. 2002,
4, 2549.
7. Jonathan, D. W.; Lynsey, G.; Chieh, C. L.; Duncan, B. J.; Stephen, C. Chem.
Commun. 2007, 1074.
8. Katritzky, A. R.; Rodriguez-Garcia, V.; Satheesh, K. N. J. Org. Chem. 2004, 69,
1849.
In terms of reactivity, these activated HOBt esters undergo ami-
dation at ambient conditions as it works for sulfonyl chlorides. This
methodology eliminates the use of expensive solvents; rather DCM
was used in most of the cases. However, sometimes sonication and
addition of DMF were necessary for better solubility. This method
offers many advantages over the existing methods for the synthe-
sis of sulfonamides: (a) the harsh bases, for example, NMM, DBU
were replaced with milder DIPEA, (b) long reaction times were re-
duced to 1–3 h, and (c) required reaction temperature was reduced
to the ambient temperature. Moreover, the current method is free
from the production of HCl, which enables it to be applicable to
those substrates in which acid labile groups such as, Boc are pres-
ent. Furthermore, as the base being used is milder, it can also be
applied to those substrates in which base labile groups like Fmoc
are present. In addition to the above advantages, N-hydroxy benzo-
triazole can be easily removed from the reaction mixture at the end
by mere washing with water.
Thus, in this letter we have shown that N-hydroxy benzotria-
zole sulfonate motif is a potential replacement for the chloride unit
of sulfonyl chloride for the synthesis of sulfonamides. Unlike the
previous activation methods in which pentaflurophenyl and tri-
chlorophenyl esters of sulfonic acids were used, current activation
undergoes amidation quite easily without the use of solvents like
NMP, high temperatures and harsh bases, retaining decent yields
even in case of complicated amines, such as, hindered amino acid
esters. Regarding the issue of cost, N-hydroxybenzotriazole is
cheaper than pentafluorophenol, while comparable to trichloro-
phenol. Therefore, these properties enable N-hydroxy benzotria-
zole sulfonate to be a good synthetic auxiliary for sulfonamide
synthesis.
9. Rich, D. H.; Singh, J. In The Peptides. Analysis, Synthesis, Biology; Gross, E.,
Meienhofer, J., Eds.; Academic Press: New York, 1979; Vol. 1, p 250.
10. Carpino, L. A.; Xia, J.; Zhang, Ch.; El-Faham, A. J. Org. Chem. 2004, 69, 62.
11. The procedure for N-benzyl-4-methylbenzene sulfonamide (Table 1, entry 1)
synthesis is described below as a representative procedure for the preparation
of sulfonamides from TsOBt and other HOBt sulfonates (see Supplementary
data): TsOBt (1 mmol, 1 equiv) is dissolved in a 1 mL DCM in an oven dried
25 mL round bottom flask which is charged with magnetic stir bar. To this,
benzyl amine (1 mmol, 1 equiv) was added followed by the addition of DIPEA
(1 mmol, 1 equiv) with 0.5 mL of DCM (for amino acid esters DCM and DMF
mixture in 1:3). Then stirring was continued at room temperature while being
monitored by TLC. After completion of the reaction, the reaction mixture was
diluted with 10 mL of DCM and washed with 5% HCl (2 Â 10 mL), 5% NaHCO3
(2 Â 10 mL), and brine solution (2 Â 10 mL). Organic fraction was dried under
CaCl2, filtered and evaporated to dryness. Then purified by column
chromatography. Rf product 0.58 (EtoAc/Hexane, 1:4) yield 75%, white solid,
Acknowledgments
mp 87–89 °C. IR (KBr, m
/cmÀ1) 3262, 3027, 1594, 1492, 1450, 1320, 1156.1H
NMR (400 MHz, CDCl3) d ppm 7.38–7.48 (m, 3H, ArH), 7.77–7.75 (d, 2H,
J = 8.4 Hz, 2 Â ArH), 7.31–7.18 (m, 7H, 7 Â ArH), 4.74 (br s, 1H, NH), 4.11(s, 2H,
CH2), 2.43 (s, 3H, CH3). LRMS (ESI) m/z 261 [M+H]+.
We are thankful to DST for XRD facility; CIF, IITG for NMR, ESI-
MS facility; DST SERC for research grant (Sanction No. SR/FT/CS-
011/2008, FAST TRACK SCHEME). PNB thanks IITG for fellowship.
Supplementary data
Supplementary data (General procedures.) associated with this
article can be found, in the online version, at doi:10.1016/